Sign in

CIK 0001868279 · Non-accelerated filer<br>Emerging growth company

ArriVent BioPharma, Inc.

Sign in to watch
Ticker
AVBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
240-780-6356
Business address
18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
  1. 8-K/A Event Executive or director change
  2. 8-K/A Event Executive or director change
  3. 8-K Event Material agreement · Regulation FD disclosure
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Executive or director change
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 8-K Event Executive or director change
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13D Stake Beneficial Ownership Report
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 4 Open-market buy 10% owner bought 555,555 shares at $18.00 ($9,999,990)
  18. 4 Open-market buy Director bought 444,444 shares at $18.00 ($7,999,992)
  19. 4 Open-market buy Director bought 444,444 shares at $18.00 ($7,999,992)
  20. 4 Open-market buy Director bought 444,444 shares at $18.00 ($7,999,992)

Page 6 of 9 · 162 filings